Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013:2013:138012.
doi: 10.1155/2013/138012. Epub 2013 Sep 10.

Cloud infrastructures for in silico drug discovery: economic and practical aspects

Affiliations

Cloud infrastructures for in silico drug discovery: economic and practical aspects

Daniele D'Agostino et al. Biomed Res Int. 2013.

Abstract

Cloud computing opens new perspectives for small-medium biotechnology laboratories that need to perform bioinformatics analysis in a flexible and effective way. This seems particularly true for hybrid clouds that couple the scalability offered by general-purpose public clouds with the greater control and ad hoc customizations supplied by the private ones. A hybrid cloud broker, acting as an intermediary between users and public providers, can support customers in the selection of the most suitable offers, optionally adding the provisioning of dedicated services with higher levels of quality. This paper analyses some economic and practical aspects of exploiting cloud computing in a real research scenario for the in silico drug discovery in terms of requirements, costs, and computational load based on the number of expected users. In particular, our work is aimed at supporting both the researchers and the cloud broker delivering an IaaS cloud infrastructure for biotechnology laboratories exposing different levels of nonfunctional requirements.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Principal operations of a typical drug discovery pipeline.
Figure 2
Figure 2
UML sequential diagram of a request for service execution in a hybrid cloud.
Figure 3
Figure 3
The brokering system architecture.
Figure 4
Figure 4
Private zone utilization U at varying arrival rates.
Figure 5
Figure 5
Annual CB's revenue.
Figure 6
Figure 6
Average waiting times, in hours, per pipeline.
Figure 7
Figure 7
Private zone utilization U with 75% sporadic users.
Figure 8
Figure 8
Annual CB's revenue with 75% sporadic users.
Figure 9
Figure 9
Average waiting times per pipeline with 75% sporadic users.
Figure 10
Figure 10
Private zone utilization U with 75% frequent users.
Figure 11
Figure 11
Annual CB's revenue with 75% frequent users.
Figure 12
Figure 12
Average waiting times per pipeline with 75% frequent users.
Figure 13
Figure 13
Private zone utilization U, with a 15-node system.
Figure 14
Figure 14
Annual CB's revenue with a 15-node system.
Figure 15
Figure 15
Percentage revenue increases with respect to the basic scenario (15 versus 10 nodes).
Figure 16
Figure 16
Average waiting times per pipeline with a 15-node system.

References

    1. Davie P. Cloud computing: a drug discovery game changer? Innovations in Pharmaceutical Technology. 2010;(33):34–36.
    1. Krampis K, Booth T, Chapman B, et al. Cloud BioLinux: pre-configured and on-demand bioinformatics computing for the genomics community. BMC Bioinformatics. 2012;13(1, article 42) - PMC - PubMed
    1. Angiuoli SV, Matalka M, Gussman A, et al. CloVR: a virtual machine for automated and portable sequence analysis from the desktop using cloud computing. BMC Bioinformatics. 2011;12, article 356 - PMC - PubMed
    1. Ferretti S, Ghini V, Panzieri F, Pellegrini M, Turrini E. QoS-aware clouds. Proceedings of the 3rd IEEE International Conference on Cloud Computing (CLOUD '10); July 2010; pp. 321–328.
    1. Ahuja SP, Mani S. The state of high performance computing in the cloud. Journal of Emerging Trends in Computing and Information Sciences. 2012;3(2):262–266.

Publication types

LinkOut - more resources